ONCY - ONCOLYTICS BIOTECH INC

QQQ $ 479.35 $ 5.42 (1.14 %)

DIA $ 391.06 $ -2.96 (-0.75 %)

SPY $ 544.78 $ 2.09 (0.39 %)

TLT $ 94.49 $ 0.16 (0.17 %)

GLD $ 214.55 $ -1.07 (-0.5 %)

Previous Close

$ 1.01

Open

$ 1.00

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 1.00 - $ 1.00

52 Week Range

$ 0.88 - $ 3.37

Volume

58,750

Average Volume

Market Cap

75.17M

Beta (5Y Monthly)

$ 1.34

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Oncolytics Biotech Chair Wayne Pisano To S...
06/24/2024 11:08:24

Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC), a leading clinical-stage company specializing in immunotherapeutics for onco...

Oncolytics Biotech Begins New Study for Ad...
06/20/2024 11:28:12

SAN DIEGO, and CALGARY, AB, June 20, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC), a leading clinical-...

Oncolytics Biotech Discloses American Soci...
05/24/2024 11:04:42

One is a trial-in-progress abstract discussing cohort 5 of the GOBLET study, which will evaluate the combination of pelareorep ...

Oncolytics Biotech Enters Preliminary Coll...
05/15/2024 11:08:20

The purpose of the preliminary collaboration is to commence planning activities for the evaluation of pelareorep in the treatme...

HC Wainwright & Co. Reiterates Buy on Onco...
05/14/2024 11:53:00

HC Wainwright & Co. analyst Patrick Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $5 pri...

Oncolytics Biotech Q1 EPS $(0.07) Beats $(...
05/09/2024 20:35:05

Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(...

Oncolytics Biotech Receives Regulatory Cle...
05/09/2024 12:01:38

Oncolytics Reports Acceptance Of Two Abstr...
04/25/2024 11:24:30

Oncolytics Biotech Has Submitted Type C Me...
04/11/2024 11:20:02

Oncolytics Biotech Reports Submission Of A...
04/11/2024 11:05:43

This meeting aims to discuss the company's planned registration-enabling trial for pelareorep in HR+/HER2- metastatic breas...

Raymond James Initiates Coverage On Oncoly...
04/04/2024 17:47:05

Raymond James analyst Rahul Sarugaser initiates coverage on Oncolytics Biotech (NASDAQ:ONCY) with a Outperform rating and an...

HC Wainwright & Co. Maintains Buy on Oncol...
03/08/2024 18:04:15

HC Wainwright & Co. analyst Patrick Trucchio maintains Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $5 pric...

Recap: Oncolytics Biotech Q4 Earnings
03/07/2024 21:10:12

Oncolytics Biotech Q4 EPS $(0.04) Beats $(...
03/07/2024 21:07:12

Oncolytics Biotech (NASDAQ:ONCY) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(...

Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

A Preview Of Oncolytics Biotech's Earnings
03/06/2024 19:02:23

Oncolytics Biotech Submits Amendment To GO...
03/05/2024 12:10:19

HC Wainwright & Co. Reiterates Buy on Onco...
02/14/2024 18:45:21

HC Wainwright & Co. analyst Patrick Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $5 pri...

HC Wainwright & Co. Reiterates Buy on Onco...
01/19/2024 12:02:44

HC Wainwright & Co. analyst Patrick Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $5 pri...

HC Wainwright & Co. Reiterates Buy on Onco...
01/04/2024 15:26:16

HC Wainwright & Co. analyst Patrick Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $5 pri...